Mirabella Financial Services LLP Sells 38,971 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Mirabella Financial Services LLP lessened its stake in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 61.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,844 shares of the medical research company's stock after selling 38,971 shares during the quarter. Mirabella Financial Services LLP's holdings in IQVIA were worth $5,887,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Fisher Asset Management LLC raised its stake in shares of IQVIA by 4.8% during the third quarter. Fisher Asset Management LLC now owns 7,398 shares of the medical research company's stock worth $1,753,000 after buying an additional 341 shares during the last quarter. Daiwa Securities Group Inc. grew its holdings in IQVIA by 5.1% during the 3rd quarter. Daiwa Securities Group Inc. now owns 37,651 shares of the medical research company's stock worth $8,922,000 after acquiring an additional 1,828 shares during the period. Centaurus Financial Inc. raised its position in shares of IQVIA by 44.2% during the 3rd quarter. Centaurus Financial Inc. now owns 4,360 shares of the medical research company's stock valued at $1,033,000 after acquiring an additional 1,337 shares during the last quarter. Larson Financial Group LLC boosted its position in shares of IQVIA by 745.1% in the 3rd quarter. Larson Financial Group LLC now owns 431 shares of the medical research company's stock worth $102,000 after purchasing an additional 380 shares during the last quarter. Finally, Swedbank AB grew its stake in shares of IQVIA by 0.9% during the third quarter. Swedbank AB now owns 91,489 shares of the medical research company's stock worth $21,680,000 after purchasing an additional 786 shares during the period. 89.62% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, insider Eric Sherbet sold 1,300 shares of the firm's stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the sale, the insider now owns 19,536 shares of the company's stock, valued at $4,812,302.88. This trade represents a 6.24 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is owned by company insiders.

IQVIA Trading Up 1.1 %

IQV stock traded up $2.20 on Monday, reaching $204.02. The company's stock had a trading volume of 2,222,202 shares, compared to its average volume of 1,178,221. IQVIA Holdings Inc. has a 12-month low of $187.62 and a 12-month high of $261.73. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The business has a fifty day simple moving average of $222.67 and a two-hundred day simple moving average of $227.16. The firm has a market cap of $37.03 billion, a PE ratio of 26.49, a PEG ratio of 2.08 and a beta of 1.51.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Redburn Atlantic started coverage on IQVIA in a report on Monday, October 14th. They set a "buy" rating and a $276.00 target price on the stock. StockNews.com raised shares of IQVIA from a "hold" rating to a "buy" rating in a research note on Wednesday, November 20th. Leerink Partners reissued an "outperform" rating and issued a $248.00 price target (down previously from $260.00) on shares of IQVIA in a report on Tuesday, November 19th. TD Cowen dropped their price objective on IQVIA from $270.00 to $255.00 and set a "buy" rating on the stock in a research note on Friday, November 1st. Finally, BTIG Research lowered their price target on IQVIA from $290.00 to $260.00 and set a "buy" rating for the company in a report on Friday, November 1st. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $256.50.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.